Innovations advancing our understanding of microglia in Alzheimer's disease: From in vitro to in vivo models
Open Access
- 15 June 2023
- journal article
- review article
- Published by Wiley in Journal of Neurochemistry
- Vol. 166 (3) , 497-516
Abstract
Microglia have been implicated in Alzheimer's disease (AD) pathogenesis through the identification of risk factor genes that are specifically or predominantly expressed in this cell type. Additional evidence suggests that microglia undergo dramatic morphological and phenotypic state changes during AD progression, as observed in human post‐mortem tissue and animal model research. Although valuable, these studies are often hampered by either representing one time point in human tissue (end point) or because of the lack of conservation between species of microglial transcriptomes, proteomes and cell states. Thus, the development and application of novel human model systems have been beneficial in the study of microglia in neurodegeneration. Recent innovations include the use of human pluripotent stem cell (hPSC)‐derived microglia in 2D or 3D culture systems, the transdifferentiation of microglia from patient monocytes and the xenotransplantation of hPSC‐derived microglia into mouse brains. This review summarizes the recent innovations that have advanced our understanding of microglia in AD, through the use of single‐cell RNA sequencing, hPSC‐derived microglia culture within brain organoids and xenotransplantation into mouse brain. Through outlining the strengths and limitations of these approaches, we provide recommendations that will aid future endeavours in advancing our understanding of the complex role of microglia in AD onset and progression. imageKeywords
This publication has 159 references indexed in Scilit:
- Microglial activation in the injured and healthy brain: What are we really talking about? Practical and theoretical issues associated with the measurement of changes in microglial morphologyNeuroscience, 2012
- Neuroprotective function for ramified microglia in hippocampal excitotoxicityJournal of Neuroinflammation, 2012
- Microglia Function in Alzheimer’s DiseaseFrontiers in Pharmacology, 2012
- Regulation of Tau Pathology by the Microglial Fractalkine ReceptorNeuron, 2010
- CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimerNature Immunology, 2009
- Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer’s diseaseActa Neuropathologica, 2009
- Toll-Like Receptor 2 Acts as a Natural Innate Immune Receptor to Clear Amyloid β1–42and Delay the Cognitive Decline in a Mouse Model of Alzheimer's DiseaseThe Journal of Neuroscience, 2008
- Microglial dystrophy in the aged and Alzheimer's disease brain is associated with ferritin immunoreactivityGlia, 2008
- Resting Microglial Cells Are Highly Dynamic Surveillants of Brain Parenchyma in VivoScience, 2005
- CD36 Mediates the Innate Host Response to β-AmyloidJournal of Experimental Medicine, 2003